Molecule Details
| InChIKey | XCGSFFUVFURLIX-VFGNJEKYSA-N |
|---|---|
| Compound Name | Ergotamine |
| Canonical SMILES | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 17 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.88 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00696 |
|---|---|
| Drug Name | Ergotamine |
| CAS Number | 113-15-5 |
| Groups | approved |
| ATC Codes | N02CA02 N02CA52 N02CA72 |
| Description | A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. |
Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Agents that produce hypertension Alkaloids Analgesics Analgesics, Non-Narcotic Antidepressive Agents Antimigraine Preparations Cardiovascular Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Inhibitors (strong) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Ergot Alkaloids and Derivatives Ergotamine Derivative Ergotamines Heterocyclic Compounds, Fused-Ring Narrow Therapeutic Index Drugs Nervous System Neurotransmitter Agents P-glycoprotein inhibitors Peripheral Nervous System Agents Reproductive Control Agents Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT1 Receptor Agonists Serotonin 5-HT2 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Sympatholytic (Adrenergic Blocking) Agents Uterotonic agents Vasoconstrictor Agents
Cross-references: BindingDB: 50027065 ChEBI: 64318 CHEMBL442 ChemSpider: 7930 Drugs Product Database (DPD): 9252 C07544 D07906 PDB: ERM PharmGKB: PA164747651 PubChem:8223 PubChem:46507632 RxCUI: 4025 Therapeutic Targets Database: DAP000141 Wikipedia: Ergotamine ZINC: ZINC000052955754
Target Activities (17)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P08913 | ADRA2A | Homo sapiens | Human | PF00001 | 8.9 | IC50 | ChEMBL |
| P50406 | HTR6 | Homo sapiens | Human | PF00001 | 8.9 | IC50 | ChEMBL |
| P28223 | HTR2A | Homo sapiens | Human | PF00001 | 8.7 | Ki | ChEMBL;BindingDB |
| P14416 | DRD2 | Homo sapiens | Human | PF00001 | 8.6 | IC50 | ChEMBL |
| P28222 | HTR1B | Homo sapiens | Human | PF00001 | 8.6 | Ki | ChEMBL;BindingDB |
| P35462 | DRD3 | Homo sapiens | Human | PF00001 | 8.6 | IC50 | ChEMBL |
| P18089 | ADRA2B | Homo sapiens | Human | PF00001 | 8.6 | IC50 | ChEMBL |
| P41595 | HTR2B | Homo sapiens | Human | PF00001 | 8.5 | Ki | ChEMBL;BindingDB |
| P28221 | HTR1D | Homo sapiens | Human | PF00001 | 8.5 | Ki | ChEMBL;BindingDB |
| P18825 | ADRA2C | Homo sapiens | Human | PF00001 | 8.3 | IC50 | ChEMBL |
| P47898 | HTR5A | Homo sapiens | Human | PF00001 | 7.7 | Ki | ChEMBL;BindingDB |
| P28335 | HTR2C | Homo sapiens | Human | PF00001 | 7.5 | Ki | ChEMBL;BindingDB |
| P25100 | ADRA1D | Homo sapiens | Human | PF00001 | 7.5 | IC50 | ChEMBL |
| P30939 | HTR1F | Homo sapiens | Human | PF00001 | 6.8 | Ki | BindingDB |
| P28566 | HTR1E | Homo sapiens | Human | PF00001 | 6.2 | Ki | BindingDB |
| P21728 | DRD1 | Homo sapiens | Human | PF00001 | 6.1 | Ki | ChEMBL |
| P08684 | CYP3A4 | Homo sapiens | Human | PF00067 | 6.0 | IC50 | ChEMBL |
DrugBank Target Actions (17)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P08908 | HTR1A | 5-hydroxytryptamine receptor 1A | agonist | targets |
| P14416 | DRD2 | D(2) dopamine receptor | agonist | targets |
| P21728 | DRD1 | D(1) dopamine receptor | agonist | targets |
| P28221 | HTR1D | 5-hydroxytryptamine receptor 1D | agonist | targets |
| P28222 | HTR1B | 5-hydroxytryptamine receptor 1B | agonist | targets |
| P28223 | HTR2A | 5-hydroxytryptamine receptor 2A | agonist | targets |
| P28335 | HTR2C | 5-hydroxytryptamine receptor 2C | agonist | targets |
| P30939 | HTR1F | 5-hydroxytryptamine receptor 1F | agonist | targets |
| P18825 | ADRA2C | Alpha-2C adrenergic receptor | binder | targets |
| P41595 | HTR2B | 5-hydroxytryptamine receptor 2B | binder | targets |
| P08913 | ADRA2A | Alpha-2A adrenergic receptor | partial agonist | targets |
| P25100 | ADRA1D | Alpha-1D adrenergic receptor | partial agonist | targets |
| P35348 | ADRA1A | Alpha-1A adrenergic receptor | partial agonist | targets |
| P35368 | ADRA1B | Alpha-1B adrenergic receptor | partial agonist | targets |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | inhibitor | transporters |